Clinical data | |
---|---|
Pronunciation | /ˌɛstrəˈdaɪoʊl ˈvæləreɪt/ ES-trə-DYE-ohl VAL-ə-rayt |
Trade names | Altadiol, Deladiol, Delestrogen, Estraval, Lastrogen, Progynon Depot, Progynova, Valergen, others |
Routes of administration |
Oral, intramuscular injection |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | Oral: 3–5% Intramuscular: 100% |
Metabolism | Cleavage via esterases in the liver, blood, and tissues |
Metabolites | Estradiol, valeric acid, and metabolites of estradiol |
Biological half-life | Oral: 12–20 hours (as E2) Intramuscular: 4–5 days |
Duration of action | Intramuscular (5 mg): 7–8 days |
Excretion | Urine (80%) |
Identifiers | |
|
|
Synonyms | Estradiol pentanoate; Estradiol valerianate |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
ECHA InfoCard | 100.012.327 |
Chemical and physical data | |
Formula | C23H32O3 |
Molar mass | 356.498 g/mol |
3D model (Jmol) | |
|
|
|
Estradiol valerate (EV, E2V) (INN, USAN, JAN) (brand names Progynova, Progynon Depot, Delestrogen, many others), or oestradiol valerate (BAN), is a synthetic, steroidal estrogen and an estrogen ester – specifically, the 17β-valerate ester of estradiol – which is marketed in the United States, Canada, Europe, and throughout much of the rest of the world. It acts as a prodrug of estradiol, and hence, is considered to be a natural, bioidentical form of estrogen. Along with estradiol cypionate, estradiol valerate is one of the most widely used esters of estradiol.
The medical uses of estradiol valerate are the same as those of estradiol and other estrogens. Examples of indications for the drug include hormone replacement therapy and hormonal contraception. In regards to the latter, estradiol valerate is available in combination with a progestogen as an combined estradiol-containing oral contraceptive (with dienogest) and as a combined injectable contraceptive (with hydroxyprogesterone caproate or norethisterone enanthate).